Physician profile
Myra C Dove
NPI 1124025655
$1,897.66
in general payments reported to CMS, 2019-2025
18 companies · $95.29 in 2025
The $95.29 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $66.18 · 2023: $1,160 · 2024: $161 · 2025: $95.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,143 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,143.20 |
| Food and Beverage | $272.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,143.20 | 2023 | Da Vinci Surgical System |
| Minerva Surgical, INC | $181.67 | 2019-2020 | |
| Daiichi Sankyo INC. | $124.99 | 2019 | |
| Mayne Pharma Commercial LLC | $78.90 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $43.00 | 2024 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $42.38 | 2019 | |
| Abbvie INC. | $41.44 | 2019-2020 | |
| Evofem Biosciences, INC. | $35.83 | 2024-2025 | Phexxi, Solosec, Phexx |
| Roche Diagnostics Corporation | $33.49 | 2019-2020 | |
| Exeltis, USA INC. | $30.37 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $24.67 | 2019-2020 | |
| Biogen, INC. | $21.91 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $19.47 | 2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $17.36 | 2019 | |
| Astellas Pharma US INC | $17.03 | 2025 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $16.16 | 2019 | |
| Shield Therapeutics INC | $13.28 | 2024 | |
| Organon LLC | $12.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myra Dove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.